Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
9 Results for "
Pam3CSK4 trihydrochloride
" in MedChemExpress (MCE) Product Catalog:
Products (9)
9 Results for "Pam3CSK4 trihydrochloride" in MCE Product Catalog:
Cat. No.: HY-P1180B
CAS No.: 112208-04-5
Synonyms: Pam3Cys-Ser-(Lys)4 trihydrochloride
Target:
Research Areas:
22
22 Publications Verification
Cat. No.: HY-P1180A
CAS No.: 112208-01-2
Synonyms: Pam3Cys-Ser-(Lys)4 TFA
Target:
Research Areas:
13
13 Cited Publications
Target:
Research Areas:
CU-CPT22 is a potent protein complex of toll-like receptor 1 and 2 (TLR1/2) inhibitor, and competes with the synthetic triacylated lipoprotein (Pam3CSK4) binding to TLR1/2 with a Ki of 0.41 µM. CU-CPT22 blocks Pam3CSK4-induced TLR1/2 activation with an IC50 of 0.58 µM .
5
5 Cited Publications
Target:
Research Areas:
MMG-11 is a potent and selective human TLR2 antagonist with low cytotoxicity. MMG-11 inhibits both TLR2/1 and TLR2/6 signaling with IC50s of 1.7 µM for Pam3CSK4-induced hTLR2/1 and 5.7 µM for Pam2CSK4-induced hTLR2/6 responses .
5
5 Cited Publications
Cat. No.: HY-112146A
Purity: 98.70%
Target:
Research Areas:
MMG-11 quarterhydrate is a potent and selective human TLR2 antagonist with low cytotoxicity. MMG-11 quarterhydrate inhibits both TLR2/1 and TLR2/6 signaling with IC50s of 1.7 μM for Pam3CSK4-induced hTLR2/1 and 5.7 μM for Pam2CSK4-induced hTLR2/6 responses .
Cat. No.: HY-P1180
CAS No.: 112208-00-1
Synonyms: Pam3Cys-Ser-(Lys)4
Target:
Research Areas:
Cat. No.: HY-P1405
CAS No.: 1429504-10-8
Synonyms: Pam3Cys-Ser-(Lys)4-Biotin
Target:
Research Areas:
Cat. No.: HY-P1405A
Synonyms: Pam3Cys-Ser-(Lys)4-Biotin TFA
Target:
Research Areas:
Cat. No.: HY-108471R
CAS No.: 1416324-85-0
Research Areas:
CU-CPT22 (Standard) is the analytical standard of CU-CPT22 (HY-108471). This product is intended for research and analytical applications. CU-CPT22 is a potent protein complex of toll-like receptor 1 and 2 (TLR1/2) inhibitor, and competes with the synthetic triacylated lipoprotein (Pam3CSK4) binding to TLR1/2 with a Ki of 0.41 µM. CU-CPT22 blocks Pam3CSK4-induced TLR1/2 activation with an IC50 of 0.58 µM .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
